Longitudinal plasma p-tau217 is increased in early stages of Alzheimer’s disease

Plasma levels of tau phosphorylated at threonine-217 (p-tau217) is a candidate tool to monitor Alzheimer’s disease. We studied 150 cognitively unimpaired participants and 100 patients with mild cognitive impairment in the Swedish BioFINDER study. P-tau217 was measured repeatedly for up to 6 years (m...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Brain
Autors principals: Mattsson-Carlgren, Niklas, Janelidze, Shorena, Palmqvist, Sebastian, Cullen, Nicholas, Svenningsson, Anna L, Strandberg, Olof, Mengel, David, Walsh, Dominic M, Stomrud, Erik, Dage, Jeffrey L, Hansson, Oskar
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2020
Matèries:
Reports
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7719022/
https://ncbi.nlm.nih.gov/pubmed/33068398
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/brain/awaa286
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars